AI assistant
Sending…
SYNOPSYS INC — Director's Dealing 2012
Mar 29, 2012
29855_dirs_2012-03-29_9f47af55-4131-4739-a656-d9adba7940df.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SYNOPSYS INC (SNPS)
CIK: 0000883241
Period of Report: 2012-03-29
Reporting Person: CHAN CHI-FOON (Director, Pres & COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-03-29 | Common Stock | M | 75000 | $26.09 | Acquired | 254234 | Direct |
| 2012-03-29 | Common Stock | S | 75000 | $31.0076 | Disposed | 179234 | Direct |
| 2012-03-29 | Common Stock | M | 44700 | $27.14 | Acquired | 223934 | Direct |
| 2012-03-29 | Common Stock | S | 44700 | $31.0076 | Disposed | 179234 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-03-29 | Non-Qualified Stock Option (right to buy) | $26.09 | M | 75000 | Disposed | 2013-12-05 | Common Stock (75000) | Direct |
| 2012-03-29 | Non-Qualified Stock Option (right to buy) | $27.14 | M | 44700 | Disposed | 2014-12-10 | Common Stock (44700) | Direct |
Footnotes
F1: All shares sold on this date sold at the average price of $31.0076. The average price conists of 53184@$ 31.0000, 1199@$ 31.0001, 100@$ 31.0007, 250@$ 31.0019, 3400@$ 31.0050, [email protected], 17188@$ 31.0100, 100@$ 31.0102, 100@$ 31.0110, 100@$ 31.0112, 350@$ 31.0123, 2900@$ 31.0150, 21562@$ 31.0200, 2200@$ 31.0300, 200@$ 31.0400,
F2: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
More from SYNOPSYS INC
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 20
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Mar 2